The European Parliament's first debate on its draft  Biotech Act report showed broad political support for strengthening Europe's biotechnology sector, while exposing disagreements over how best to boost innovation, streamline clinical trials and incentivise investment. Presenting their joint report, co-rapporteurs Wouter Beke MEP (EPP, Belgium)